Myasthenia Gravis Treatment Updates

被引：0
|
作者：
Elena Cortés-Vicente
Eduard Gallardo
Rodrigo Álvarez-Velasco
Isabel Illa
机构：
[1] Hospital de la Santa Creu i Sant Pau,Neuromuscular Diseases Unit, Department of Neurology
[2] Universitat Autònoma de Barcelona,Department of Medicine
[3] Universitat Autónoma de Barcelona,Neuromuscular Diseases Laboratory
[4] Instituto de Salud Carlos III, Biomedical Research Institute Sant Pau
来源：
Current Treatment Options in Neurology | 2020年 / 22卷
关键词：
Myasthenia gravis; Treatment; Rituximab; Immunoglobulin; Eculizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Cyclosporine in the treatment of myasthenia gravis
    Lavrnic, D
    Vujic, A
    Rakocevic-Stojanovic, V
    Stevic, Z
    Basta, I
    Pavlovic, S
    Trikic, R
    Apostolski, S
    ACTA NEUROLOGICA SCANDINAVICA, 2005, 111 (04): : 247 - 252
  • [42] Novel Immunotherapies for Myasthenia Gravis
    Nair, Sruthi S.
    Jacob, Saiju
    IMMUNOTARGETS AND THERAPY, 2023, 12 : 25 - 45
  • [43] Treatment of Ocular Myasthenia Gravis
    Haines, Scott R.
    Thurtell, Matthew J.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2012, 14 (01) : 103 - 112
  • [44] Myasthenia gravis and the neuromuscular junction
    Querol, Luis
    Illa, Isabel
    CURRENT OPINION IN NEUROLOGY, 2013, 26 (05) : 459 - 465
  • [45] Emerging therapies for autoimmune myasthenia gravis: Towards treatment without corticosteroids
    Tannemaat, Martijn R.
    Verschuuren, Jan J. G. M.
    NEUROMUSCULAR DISORDERS, 2020, 30 (02) : 111 - 119
  • [46] When myasthenia gravis is deemed refractory: clinical signposts and treatment strategies
    Mantegazza, Renato
    Antozzi, Carlo
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2018, 11 : 1 - 11
  • [47] Clinical experience with rituximab in the management of patients with myasthenia gravis refractory to conventional treatment
    Guido, Guenther
    Lilia, Nunez-Orozco
    REVISTA MEXICANA DE NEUROCIENCIA, 2011, 12 (06): : 340 - 345
  • [48] Eculizumab treatment for myasthenia gravis subgroups: 2021 update
    Jiao, Li
    Li, Honghao
    Guo, Shougang
    JOURNAL OF NEUROIMMUNOLOGY, 2022, 362
  • [49] Current pharmacotherapeutic options for myasthenia gravis
    Barnett, Carolina
    Tabasinejad, Raha
    Bril, Vera
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (18) : 2295 - 2303
  • [50] RITUXIMAB IN THE MANAGEMENT OF REFRACTORY MYASTHENIA GRAVIS
    Zebardast, Nazlee
    Patwa, Huned S.
    Novella, Steven P.
    Goldstein, Jonathan M.
    MUSCLE & NERVE, 2010, 41 (03) : 375 - 378
12345